Finance

Lists
BIOG-B:STO
BioGaia AB
SEK 115,20
+1,05%
(+1,20) 1D
5 Okt., 17:29:55 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for BIOG-B...
Open
SEK 114,00
High
SEK 117,20
Low
SEK 113,50
Mkt. cap
11,23 mjd
Avg. vol.
182,19 k
Volume
105,64 k
52-wk high
SEK 136,30
52-wk low
SEK 96,20
Shares outstanding
98,50 m
No. of employees
251
Open
SEK 114,00
High
SEK 117,20
Low
SEK 113,50
Mkt. cap
11,23 mjd
Avg. vol.
182,19 k
Volume
105,64 k
52-wk high
SEK 136,30
52-wk low
SEK 96,20
Shares outstanding
98,50 m
No. of employees
251
News stories
From web sources and news partners
Profile
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
About BioGaia AB
CEOTheresa Agnew
Employees251
Founded1990
Headquarters-
Sector-
Websitebiogaiagroup.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
326,64 m
440,57 m
372,55 m
440,86 m
Cost of goods sold
84,13 m
116,74 m
105,77 m
119,98 m
Cost of revenue
84,13 m
116,74 m
105,77 m
119,98 m
Research and development expenses
25,88 m
36,79 m
25,53 m
28,24 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
126,67 m
159,68 m
145,89 m
167,47 m
Operating expense
152,54 m
196,47 m
171,42 m
195,71 m
Total operating expenses
236,68 m
313,21 m
277,19 m
315,69 m
Operating income
89,96 m
127,36 m
95,36 m
125,17 m
Other non operating income
1,00 k
-2,39 m
285,00 k
-1,00 k
EBT including unusual items
85,32 m
123,58 m
101,50 m
134,03 m
EBT excluding unusual items
87,52 m
117,88 m
103,78 m
134,03 m
Income tax expense
19,44 m
24,80 m
22,10 m
30,88 m
Effective tax rate
22,78%
20,07%
21,77%
23,04%
Other operating expenses
-
-
-
-
Net income
65,88 m
98,78 m
79,41 m
103,16 m
Net profit margin
20,17%
22,42%
21,32%
23,40%
Earnings per share
0,65
0,98
0,78
1,11
Interest and investment income
2,93 m
2,81 m
2,34 m
2,01 m
Interest expense
-1,39 m
-3,49 m
-
-62,00 k
Net interest expenses
1,54 m
-677,00 k
2,34 m
1,95 m
Depreciation and amortization charges
-
-
-
-
EBITDA
96,10 m
133,49 m
101,50 m
131,21 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme